We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ATOS market cap is 229.31M. The company's latest EPS is USD -0.2152 and P/E is -8.32.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -8.21M | -8.14M | -7.1M | -7.79M | -7.47M |
Net Income | -8.01M | -7.49M | -6.28M | -9.83M | -6.23M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -11.43M | -17.27M | -15.55M | -20.61M | -27.69M |
Net Income | -22.88M | -17.24M | -22.33M | -20.61M | -26.96M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 126.72M | 123.53M | 116.2M | 108.36M | 101.7M |
Total Liabilities | 2.87M | 5.57M | 2.94M | 3.48M | 3.44M |
Total Equity | 123.86M | 117.96M | 113.26M | 104.88M | 98.25M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 11.72M | 14.49M | 42.84M | 141.26M | 123.53M |
Total Liabilities | 2.92M | 1.33M | 15.67M | 3.13M | 5.57M |
Total Equity | 8.81M | 13.16M | 27.17M | 138.14M | 117.96M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -16.24M | -20.76M | -7.02M | -11.49M | -15.37M |
Investing | -2.72M | -4.73M | N/A | -13k | -14k |
Financing | N/A | N/A | N/A | N/A | -1.48M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -8.96M | -9.13M | -11.57M | -16.47M | -20.76M |
Investing | -111k | -8k | -9k | -9k | -4.73M |
Financing | 12.29M | 11.34M | 38.55M | 113.3M | N/A |
Market Cap | 229.31M |
Price to Earnings Ratio | -8.32 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 2.02 |
Price to Book Ratio | 1.9 |
Dividend Yield | - |
Shares Outstanding | 125.3M |
Average Volume (1 week) | 2.79M |
Average Volume (1 Month) | 2.04M |
52 Week Change | 178.03% |
52 Week High | 1.94 |
52 Week Low | 0.5901 |
Spread (Intraday) | 0.03 (1.64%) |
Company Name | Atossa Therapeutics Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.atossatherapeutics.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions